Clotrimazole Cream
FDA Recall NDC 69396-087

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 2 recorded enforcement report(s) associated with Clotrimazole (NDC 69396-087). A significant event, classified as Class II, was initiated on Oct 31, 2025 by Trifecta Pharmaceuticals Usa Llc. The reported reason for this action was: "cGMP deviations"

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

October 2025 Class II Recall: cGMP deviations

Recall Number
Class II Ongoing
Reason for Recall
cGMP deviations
Initiated
Oct 31, 2025
Reported
Dec 10, 2025
Quantity
12150 bottles

Recall Profile & Regulatory Data

Event ID
97935
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Blossom Pharmaceuticals
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide
Product Description
Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.
Batch or Lot Expiration Information
Lot# : A472408
Affected Packages Involved in this Recall
69396-087-01Product
69396-087-55Product

October 2025 Class II Recall: cGMP deviations

Recall Number
Class II Ongoing
Reason for Recall
cGMP deviations
Initiated
Oct 31, 2025
Reported
Dec 10, 2025
Quantity
14700 bottles

Recall Profile & Regulatory Data

Event ID
97935
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Blossom Pharmaceuticals
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide
Product Description
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.
Batch or Lot Expiration Information
Lot# : A472418
Affected Packages Involved in this Recall
69396-087-01Product
69396-087-55Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.